Baystate Wealth Management LLC Amgen Inc Transaction History

Baystate Wealth Management LLC

$1.36 Billion
Q4 2023

A detailed history of Baystate Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Baystate Wealth Management LLC holds 1,980 shares of AMGN stock, worth $554,538. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,980

Previous 1,965 0.76%

Holding current value

$554,538

Previous $528,000 7.95%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$255.7 - $288.46 $3,835 - $4,326	15 Added 0.76%	1,980 $570,000
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $6,559 - $8,143	30 Added 1.55%	1,965 $528,000
Q2 2023 Sep 21, 2023	SELL	$214.27 - $253.37 $2.13 Million - $2.52 Million	-9,941 Reduced 83.71%	1,935 $429,000
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $2.14 Million - $2.54 Million	10,009 Added 536.1%	11,876 $2.64 Million
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $1,128 - $1,376	-5 Reduced 0.27%	1,867 $451,000
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $4,580 - $5,820	-20 Reduced 1.06%	1,872 $492,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $3,366 - $3,797	15 Added 0.8%	1,892 $427,000
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $3,229 - $3,594	14 Added 0.75%	1,877 $457,000
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $3,289 - $3,638	15 Added 0.81%	1,863 $451,000
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $11,733 - $13,428	59 Added 3.3%	1,848 $416,000
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $2,971 - $3,481	14 Added 0.79%	1,789 $380,000
Q2 2021 Jul 26, 2021	BUY	$233.58 - $259.14 $9,576 - $10,624	41 Added 2.36%	1,775 $433,000
Q1 2021 Apr 21, 2021	SELL	$221.91 - $258.6 $5,103 - $5,947	-23 Reduced 1.31%	1,734 $432,000
Q4 2020 Jan 15, 2021	SELL	$216.38 - $257.67 $8,871 - $10,564	-41 Reduced 2.28%	1,757 $404,000
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $15,017 - $16,700	64 Added 3.69%	1,798 $457,000
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $22,550 - $27,672	-114 Reduced 6.17%	1,734 $409,000
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $26,607 - $35,288	-146 Reduced 7.32%	1,848 $375,000
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $88,739 - $114,060	469 Added 30.75%	1,994 $481,000
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $1,218 - $1,460	-7 Reduced 0.46%	1,525 $295,000
Q2 2019 Jul 02, 2019	BUY	$166.7 - $195.41 $238,714 - $279,827	1,432 Added 1432.0%	1,532 $286,000
Q1 2019 Apr 25, 2019	BUY	$180.87 - $203.88 $6,511 - $7,339	36 Added 56.25%	100 $18,000
Q4 2018 Jan 24, 2019	BUY	$178.4 - $208.25 $178 - $208	1 Added 1.59%	64 $13,000
Q2 2018 Jul 17, 2018	BUY	$166.05 - $186.51 $3,487 - $3,916	21 Added 50.0%	63 $12,000
Q3 2017 Oct 10, 2017	BUY	$167.29 - $191.0 $7,026 - $8,022	42	42 $8,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.

Account

Baystate Wealth Management LLC Amgen Inc Transaction History